# Ganirelix Acetate

NDC: 0548-5001
Generic name: Ganirelix Acetate
Labeler / Manufacturer: Amphastar Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: SUBCUTANEOUS
Marketing started: 20220620

FDA application: ANDA212613

## Active ingredients

- GANIRELIX ACETATE: 250 ug/.5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0548-5001"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0548-5001
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9c286f64-8039-44ec-8fdd-d1a2f52b4c3c